ID
29541
Descripción
Study ID: 102871 Clinical Study ID: HZC102871 Study Title:HZC102871: A 52-week efficacy and safety study to compare the effect of three dosage strengths of Fluticasone Furoate/GW642444 Inhalation Powder with GW642444 on the Annual Rate of Exacerbations in Subjects with Chronic Obstructive Pulmonary Disease (COPD) Patient Level Data: Study Listed on ClinicalStudyDataRequest.com Clinicaltrials.gov Identifier: NCT01009463 Sponsor: GlaxoSmithKline Collaborators: N/A Phase: Phase 3 Study Recruitment Status: Completed Generic Name: fluticasone furoate Trade Name: Veramyst,Avamys,Allermist Study Indication: Pulmonary Disease, Chronic Obstructive Documentation part: Chest X-Ray
Palabras clave
Versiones (1)
- 5/4/18 5/4/18 -
Titular de derechos de autor
GlaxoSmithKline
Subido en
5 de abril de 2018
DOI
Para solicitar uno, por favor iniciar sesión.
Licencia
Creative Commons BY-NC 3.0
Comentarios del modelo :
Puede comentar sobre el modelo de datos aquí. A través de las burbujas de diálogo en los grupos de elementos y elementos, puede agregar comentarios específicos.
Comentarios de grupo de elementos para :
Comentarios del elemento para :
Para descargar modelos de datos, debe haber iniciado sesión. Por favor iniciar sesión o Registrate gratis.
GSK Efficacy and safety of Fluticasone on the Annual Rate of Exacerbations in Subjects with Chronic Obstructive Pulmonary Disease (COPD) NCT01009463
Similar models
Chest X-Ray
- StudyEvent: ODM
C0011008 (UMLS CUI [1,2])
C0238767 (UMLS CUI [2])
C0205092 (UMLS CUI [3])
C0678257 (UMLS CUI [1,2])
C0235896 (UMLS CUI [1,2])
C0235896 (UMLS CUI [1,2])
C0235896 (UMLS CUI [1,2])
C0235896 (UMLS CUI [1,2])
C0235896 (UMLS CUI [1,2])
C0235896 (UMLS CUI [1,2])
C1515974 (UMLS CUI [1,2])
C0947611 (UMLS CUI [1,2])